Editas Medicine Inc (EDIT)
9.67
+0.12
(+1.26%)
USD |
NASDAQ |
Jun 02, 16:00
9.67
0.00 (0.00%)
After-Hours: 20:00
Editas Medicine Cash from Operations (TTM): -163.89M for March 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2023 | -163.89M |
December 31, 2022 | -177.35M |
September 30, 2022 | -169.66M |
June 30, 2022 | -162.44M |
March 31, 2022 | -163.55M |
December 31, 2021 | -163.80M |
September 30, 2021 | -169.32M |
June 30, 2021 | -183.34M |
March 31, 2021 | -175.24M |
December 31, 2020 | -179.84M |
September 30, 2020 | -98.72M |
June 30, 2020 | -70.80M |
March 31, 2020 | -65.75M |
December 31, 2019 | -40.67M |
September 30, 2019 | -80.37M |
Date | Value |
---|---|
June 30, 2019 | -61.32M |
March 31, 2019 | -52.25M |
December 31, 2018 | -45.71M |
September 30, 2018 | -72.10M |
June 30, 2018 | -92.24M |
March 31, 2018 | -101.67M |
December 31, 2017 | -9.417M |
September 30, 2017 | 1.975M |
June 30, 2017 | 12.91M |
March 31, 2017 | 29.17M |
December 31, 2016 | -50.25M |
September 30, 2016 | -44.58M |
June 30, 2016 | -39.48M |
March 31, 2016 | -9.129M |
December 31, 2015 | -5.443M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-183.34M
Minimum
Jun 2021
-40.67M
Maximum
Dec 2019
-119.42M
Average
-130.58M
Median
Cash from Operations (TTM) Benchmarks
Twist Bioscience Corp | -133.75M |
Beam Therapeutics Inc | -305.78M |
Vertex Pharmaceuticals Inc | 4.074B |
Intellia Therapeutics Inc | -362.81M |
Ocugen Inc | -63.25M |